NCOA2 and cancer: For clinically locally advanced cancer, SRC-1 (p < 0.005), SRC-2 (p < 0.0005), SRC-3 (p < 0.05), AR (p < 0.05), and AR-V7 (p < 0.0005) super-expression were significantly associated with locally advanced cancer.